umbilical cord generated dendritic cell immunotherapy (BRS-001) / Therapeutic Solutions - LARVOL DELTA

"Go $TSOI - TAST & StemVacs synergies - the ‘1-2 punch’ to treat/kill cancer tumors! @ratpackstocks @coachnickmoney @BreastCancerNow @LivingBeyondBC @Breastcancerorg @keepabreast @BCRFcure @BCCare @BCAction @BreastCancerH @AACR @AmericanCancer @NCCN @SU2C @CancerTodayMag" (@rrao111)

Breast Cancer • Oncology • Solid Tumor

Therapeutic Solutions International Uses StemVacs Platform to Generate Personalized Adoptive T Cell Therapy Targeting Cancer Stem Cells (PRNewswire) - "Therapeutic Solutions International, Inc...reported today novel data and filing of a patent application demonstrating that StemVacs™ cells carrying proprietary sequences from the cancer-specific antigen Brother of the Regulator of Imprinted Sites (BORIS), were able to elicit the generation of T cells capable of selectively killing cancer stem cells."

Patent • Oncology

Therapeutic Solutions International Reports Preliminary Data Suggesting StemVacs Induces Natural Killer Memory to Cancer (PRNewswire) - "Therapeutic Solutions International, Inc...announced...filing of a new patent application with data demonstrating that mice immunized with StemVacs possesses a type of 'memory' natural killer cells which are capable of transferring immunity to naïve mice. Typically, the concept of 'immunological memory' applies only to cells of the adaptive immune system such as T cells and B cells, but not to natural killer cells, which are considered part of innate immunity....The mice receiving NK cells were resistant to development of melanoma upon challenge."

Patent • Melanoma • Oncology

Therapeutic Solutions International Reports Successful Treatment of Breast Cancer using StemVacs Cellular Immunotherapy (PRNewswire) - "Therapeutic Solutions International, Inc...reported positive animal data in the 4T1 breast cancer model using its clinically tested StemVacs™ cellular immunotherapy...Additionally, the Company has filed an Investigational New Drug Application (IND) which is currently pending based on the Company responding to questions posed by the FDA."

IND • Preclinical • Breast Cancer • Oncology

"$TSOI Therapeutic Solutions International Reports Therapeutic Efficacy of StemVacs Derived Exosomes in Regression of Glioma https://t.co/W00uOJnNzS" (@otcdynamics)

Clinical • Glioma • Oncology • Solid Tumor

Therapeutic Solutions International Reports Regression of Glioma, Lung Cancer and Colorectal Cancer using StemVacs in Animal Models (PRNewswire) - "Therapeutic Solutions International, Inc...announced...expansion of its preclinical dataset on StemVacs, an umbilical cord generated dendritic cell immunotherapy. In a series of laboratory experiments, StemVacs administration was demonstrated to induce regression of GL261 glioma, CT-26 colorectal cancer, and Lewis Lung Carcinoma tumors grown in mice....Mechanistically, regression in glioma, colorectal and lung cancer was also dependent on mice possessing a functional natural killer cells repertoire."

Preclinical • Colorectal Cancer • Gastrointestinal Cancer • Glioma • Lung Cancer • Oncology

Therapeutic Solutions International Reports Therapeutic Efficacy of StemVacs Derived Exosomes in Regression of Glioma (PRNewswire) - "Therapeutic Solutions International, Inc...reported today new data demonstrating regression of an animal model of glioma using exosomes isolated from the Company's cellular immunotherapy product StemVacs...Exosomes are cell derived nanoparticles which have been demonstrated to transmit biological information between cells."

Preclinical • Brain Cancer • Glioma • Oncology